Heart Test Laboratories I... (HSCS)
NASDAQ: HSCS
· Real-Time Price · USD
3.59
0.11 (3.16%)
At close: May 02, 2025, 2:47 PM
3.16% (1D)
| Bid | 3.5 |
| Market Cap | 3.88M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -2.54B |
| EPS (ttm) | -7.61 |
| PE Ratio (ttm) | -0.47 |
| Forward PE | -0.48 |
| Analyst | Buy |
| Ask | 3.6 |
| Volume | 9,262 |
| Avg. Volume (20D) | 19,554.1 |
| Open | 3.49 |
| Previous Close | 3.48 |
| Day's Range | 3.48 - 3.65 |
| 52-Week Range | 2.36 - 13.50 |
| Beta | 2.73 |
About HSCS
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake...
Industry Medical - Devices
Sector Healthcare
IPO Date Jun 16, 2022
Employees 15
Stock Exchange NASDAQ
Ticker Symbol HSCS
Website https://heartsciences.com
Analyst Forecast
According to 3 analyst ratings, the average rating for HSCS stock is "Buy." The 12-month stock price forecast is $14, which is an increase of 289.97% from the latest price.
Stock Forecasts
